TPD52 and prostate carcinoma: This implies that the CRPC associated increased PC-1 expression may not respond due to AR variants that lack the hinge region being able to potentially escape PC-1-mediated degradation, thus maintaining high transcriptional activity and contributing to prostate cancer progression.